Kintara Seeking $15.0M In PIPE
socalTECH
SEPTEMBER 24, 2021
The company--which is novel cancer therapies for patients who are failing, or are resistant to, current treatment regimens--currently trades on the Nasdaq as KTRA. The company said the exclusive placement agent on the offering is H.C. Wainwright & Co.
Let's personalize your content